Morris Goldman, M.D.
Associate Professor of Psychiatry, University of Chicago Director, University of Chicago Research Program at the Psychiatric Institute
Phone: (312) 413-4591
E-mail: Mgoldman@psych.uic.edu

Dr. Goldman is an Associate Professor of Psychiatry at the Pritzker University School of Medicine, University of Chicago and a lecturer at the University of Illinois at Chicago.  He was born and raised in Phoenix, Arizona, completed his Bachelors Degree, summa cum laude, in Chemistry at Occidental College in 1975; his Medical Degree at University of Pennsylvania in 1980, his residency in psychiatry at University of Chicago in 1984, and a NIMH-sponsored neuroendocrine fellowship in 1986. He has been Board Certified by the American Board of Psychiatry and Neurology since 1985. He has received other fellowships from the National Science Foundation and National Fund for Medical Education, and was recognized as the Mentor of the Year by the Illinois Psychiatric Association. He has published in the New England Journal of Medicine, The Lancet, basic science journals including Brain Research and JCI, as well as the major journals in Psychiatry. Since 1989 he has been a research psychiatrist at the Illinois State Psychiatric Institute and is now the Program Director of the University of Chicago research program at the Psychiatric Institute. Additional information about Dr. Goldman's current clinical and research activities  is available on his University of Chicago Web Page.

Dr. Goldman's research interests have been to improve the treatment and clarify the mechanisms of the  life threatening water imbalance that afflicts about 3 to 5 % of chronic schizophrenic patients. More recently the focus has been on clarifying the relationship between these patients' (i.e. hyponatremic polydipsic schizophrenics)  enhanced activity of the antidiuretic hormone, arginine vasopressin, and their underlying neuropsychiatric disorder. Specifically, he is now testing the hypothesis that their neuropsychiatric disorder  is caused by an imagable hippocampal lesion which  disrupts the  constraint of  their neuroendocrine, behavioral, affective and cognitive responses to psychological stress. His research is currently funded by the NIH (R01MH56525), an investigator initiated grant with Eli Lilly, the University of Chicago Brain Research Foundation, and the University of Illinois sub-contract with the University of Chicago. 

A summary of the previous work of his lab, its current (5/2000) and future direction (particularly fMRI) is also available. The references included with this summary identify many of this group's contributions, as well as those that have influenced its work. Additional information can be obtained by contacting Dr. Goldman or  his secretary.